Mycoplasma Bovis in Bison 2022 Case Control Study

ICR 202203-0579-005

OMB: 0579-0482

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2022-04-11
Supplementary Document
2022-03-30
Supplementary Document
2022-03-30
Supplementary Document
2022-03-30
Supporting Statement B
2022-03-30
IC Document Collections
IC ID
Document
Title
Status
252451 New
ICR Details
0579-0482 202203-0579-005
Active
USDA/APHIS
Mycoplasma Bovis in Bison 2022 Case Control Study
New collection (Request for a new OMB Control Number)   No
Emergency 04/15/2022
Approved without change 04/12/2022
Retrieve Notice of Action (NOA) 04/12/2022
  Inventory as of this Action Requested Previously Approved
10/31/2022 6 Months From Approved
220 0 0
55 0 0
0 0 0

This study will collect information needed to identify risk factors for the rapidly spreading pathogen Mycoplasma bovis in bison. Identifying these risk factors is critical for developing disease prevention and control recommendations.
This study will generate information needed to identify risk factors for the rapidly spreading pathogen Mycoplasma bovis in bison herds. Identifying the risk factors is critical for developing disease prevention and control recommendations. These recommendations are necessary because there are no effective treatments or vaccines currently for this pathogen and resulting mortality losses are high and recurring. The result for bison producers is significant economic losses, cultural losses for Native American tribes, and threatening conservation efforts for the Nation’s wild bison populations.

None
None

Not associated with rulemaking

No

1
IC Title Form No. Form Name
Private Sector

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 220 0 0 220 0 0
Annual Time Burden (Hours) 55 0 0 55 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new information collection package needed to develop countermeasures for Mycoplasma Bovis disease outbreak in U.S. bison herds.

$34,983
Yes Part B of Supporting Statement
    No
    No
No
No
No
No
William Kelley 970 494-7270

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
04/12/2022


© 2024 OMB.report | Privacy Policy